⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2641245 | 0.69 | — | — | |
| SCHEMBL14988849 | 0.65 | — | — | |
| SCHEMBL857558 | 0.65 | — | — | |
| Butadiene SCHEMBL27973106 | 0.61 | — | — | |
| SCHEMBL176519 | 0.61 | — | — | |
| Butadiene SCHEMBL5086702 | 0.60 | LMNA (0.54) | — | |
| Butadiene SCHEMBL37186 | 0.60 | — | — | |
| SCHEMBL2512586 | 0.60 | — | — | |
| SCHEMBL29042034 | 0.59 | — | — | |
| Oxalic Acid SCHEMBL17985765 | 0.57 | LMNA (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5387671-A | Antiinflammatory agents | ABBOTT LABORATORIES (US) | 1995-02-07 | — | — | US | claimed |
| US-5386011-A | Antiinflammatory agents; also, peptidomimetic compounds, i,e., agonists, having immunoregulatory effect against infections and cancer | ABBOTT LABORATORIES (US) | 1995-01-31 | — | — | US | claimed |
| EP-0564533-A4 | MODIFIED HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS | ABBOTT LAB (US) | 1994-11-02 | — | — | EP | claimed |
| EP-0564588-A4 | HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS | — | 1993-12-29 | — | — | EP | claimed |
| EP-0564588-A1 | HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS. | ABBOTT LAB (US) | 1993-10-13 | — | — | EP | claimed |
| EP-0564533-A1 | MODIFIED PENTA- AND HEXAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1993-10-13 | — | — | EP | claimed |
| US-5223485-A | Oligopeptides as antiinflammatory agents | ABBOTT LABORATORIES (US) | 1993-06-29 | — | — | US | claimed |
| WO-1992011858-A1 | HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1992-07-23 | — | — | WO | claimed |
| WO-1992012168-A1 | MODIFIED HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1992-07-23 | — | — | WO | claimed |
| EP-0456758-A1 | ANAPHYLATOXIN-RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1991-11-21 | — | — | EP | claimed |
| US-5387671-A | Antiinflammatory agents | ABBOTT LABORATORIES (US) | 1995-02-07 | — | — | US | disclosed |
| US-5386011-A | Antiinflammatory agents; also, peptidomimetic compounds, i,e., agonists, having immunoregulatory effect against infections and cancer | ABBOTT LABORATORIES (US) | 1995-01-31 | — | — | US | disclosed |
| EP-0564533-A4 | MODIFIED HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS | ABBOTT LAB (US) | 1994-11-02 | — | — | EP | disclosed |
| EP-0564588-A4 | HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS | — | 1993-12-29 | — | — | EP | disclosed |
| EP-0564533-A1 | MODIFIED PENTA- AND HEXAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1993-10-13 | — | — | EP | disclosed |
| US-5190922-A | Antiinflammatory | ABBOTT LABORATORIES (US) | 1993-03-02 | — | — | US | disclosed |
| WO-1992021361-A1 | TERMINALLY MODIFIED TRI-, TETRA- AND PENTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1992-12-10 | — | — | WO | disclosed |
| WO-1992011858-A1 | HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1992-07-23 | — | — | WO | disclosed |
| WO-1992012168-A1 | MODIFIED HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1992-07-23 | — | — | WO | disclosed |
| EP-0456758-A1 | ANAPHYLATOXIN-RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 1991-11-21 | — | — | EP | disclosed |